NCT06783582 Effectiveness of Motivational Interviewing in Patients With COPD
| NCT ID | NCT06783582 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Zeynep Yildirim |
| Condition | COPD |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-03-29 |
| Primary Completion | 2025-02-24 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2024-03-29 with a primary completion date of 2025-02-24.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To determine the effect of motivational interviewing based on Pender's health promotion model on patient-reported outcomes in patients with COPD.
Eligibility Criteria
Inclusion Criteria: * Being over 18 years of age, * Volunteering to participate in the study, * Being literate, * Having GOLD Stage II and III COPD, * Receiving COPD treatment for more than 6 months, * Having a smartphone for online interviews, * Not having sensory loss related to hearing and vision, * Not having a history of psychiatric diagnosis, * Being suitable for applying cognitive level scales. Exclusion Criteria: * Having GOLD Stage I and IV COPD, * Having serious pulmonary and malignant disease, * Not being able to communicate in Turkish, * Being in an exacerbation period, * Having a history of psychiatric diagnosis.
Frequently Asked Questions
Who can join the NCT06783582 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying COPD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06783582 currently recruiting?
Yes, NCT06783582 is actively recruiting participants. Visit ClinicalTrials.gov or contact Zeynep Yildirim to inquire about joining.
Where is the NCT06783582 trial being conducted?
This trial is being conducted at Erzurum, Turkey (Türkiye).
Who is sponsoring the NCT06783582 clinical trial?
NCT06783582 is sponsored by Zeynep Yildirim. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.